Thus, the crucial role of Batf3-dependent DCs, differentially imprinting Th responses in the different forms of leishmaniasis, reinforces the possibility of designing vaccines or targeted immunotherapies based on delivery of parasite antigens to this type of DCs. This evidence concerns the gene BATF3 and leishmaniasis.